3.8 Article

Computed Tomography of the Chest to Screen for Interstitial Lung Disease in Patients With Systemic Sclerosis at Expert Scleroderma Centers in the United States

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Rheumatology

Does hand involvement in systemic sclerosis limit completion of patient-reported outcome measures?

Tracy M. Frech et al.

Summary: The study aimed to investigate the impact of systemic sclerosis (SSc) hand involvement on patient-reported outcome measure (PROM) completion rates. Results showed that calcinosis and acro-osteolysis were significantly associated with incomplete PROM, with the Resource Use Questionnaire being the most commonly uncompleted PROM.

CLINICAL RHEUMATOLOGY (2021)

Article Rheumatology

Tocilizumab Prevents Progression of Early Systemic Sclerosis-Associated Interstitial Lung Disease

David Roofeh et al.

Summary: Tocilizumab has been shown to preserve lung function in early SSc, regardless of the extent of radiographically evident lung involvement, with a significant stabilization of FVC% over 48 weeks.

ARTHRITIS & RHEUMATOLOGY (2021)

Article Medicine, General & Internal

Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease

Oliver Distler et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Critical Care Medicine

Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort

Anna-Maria Hoffmann-Vold et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)

Article Rheumatology

Mapping and predicting mortality from systemic sclerosis

Muriel Elhai et al.

ANNALS OF THE RHEUMATIC DISEASES (2017)

Article Radiology, Nuclear Medicine & Medical Imaging

Estimated Radiation Dose Associated With Low-Dose Chest CT of Average-Size Participants in the National Lung Screening Trial

Frederick J. Larke et al.

AMERICAN JOURNAL OF ROENTGENOLOGY (2011)

Article Rheumatology

Changes in causes of death in systemic sclerosis, 1972-2002

Virginia D. Steen et al.

ANNALS OF THE RHEUMATIC DISEASES (2007)

Article Medicine, General & Internal

Cyclophosphamide versus placebo in scleroderma lung disease

Donald P. Tashkin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)